Co-Authors
This is a "connection" page, showing publications co-authored by Allan Massie and Jacqueline Garonzik-Wang.
Connection Strength
5.627
-
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):2170-2174.
Score: 0.243
-
Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123.
Score: 0.241
-
Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021 08 01; 105(8):e82-e83.
Score: 0.240
-
Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine. Transplant Direct. 2021 Jul; 7(7):e713.
Score: 0.238
-
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021 06 01; 325(21):2204-2206.
Score: 0.237
-
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021 05 04; 325(17):1784-1786.
Score: 0.236
-
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 05 01; 105(5):e56-e57.
Score: 0.236
-
Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study. Transplantation. 2021 05 01; 105(5):e52-e53.
Score: 0.236
-
Response to "COVID-19 in SOT versus non-SOT". Am J Transplant. 2021 06; 21(6):2306.
Score: 0.233
-
Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort. Am J Transplant. 2021 07; 21(7):2498-2508.
Score: 0.233
-
Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses. Am J Transplant. 2021 05; 21(5):1838-1847.
Score: 0.228
-
Evolving Impact of COVID-19 on Transplant Center Practices and Policies in the United States. Clin Transplant. 2020 12; 34(12):e14086.
Score: 0.226
-
Effects of COVID-19 pandemic on pediatric kidney transplant in the United States. Pediatr Nephrol. 2021 01; 36(1):143-151.
Score: 0.226
-
Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. 2020 11; 20(11):3131-3139.
Score: 0.224
-
Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study. Am J Transplant. 2020 11; 20(11):2997-3007.
Score: 0.223
-
Early Experiences With COVID-19 Testing in Transplantation. Transplant Direct. 2020 Jul; 6(7):e572.
Score: 0.222
-
Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. 2020 07; 20(7):1809-1818.
Score: 0.220
-
National Variation in Increased Infectious Risk Kidney Offer Acceptance. Transplantation. 2019 10; 103(10):2157-2163.
Score: 0.211
-
Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients. Transplantation. 2019 06; 103(6):1267-1271.
Score: 0.206
-
Pediatric deceased donor kidney transplant outcomes under the Kidney Allocation System. Am J Transplant. 2019 11; 19(11):3079-3086.
Score: 0.206
-
Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States. Transplantation. 2018 04; 102(4):609-615.
Score: 0.190
-
Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2021 12 01; 105(12):e280-e281.
Score: 0.061
-
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271.
Score: 0.061
-
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138.
Score: 0.061
-
Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856.
Score: 0.060
-
Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1365-1366.
Score: 0.060
-
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021 12; 40(12):1579-1588.
Score: 0.060
-
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 09; 174(9):1330-1332.
Score: 0.059
-
Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. Transplantation. 2021 01 01; 105(1):216-224.
Score: 0.058
-
Perspectives on implementing mobile health technology for living kidney donor follow-up: In-depth interviews with transplant providers. Clin Transplant. 2019 08; 33(8):e13637.
Score: 0.052
-
Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study. Transplantation. 2019 06; 103(6):1216-1223.
Score: 0.052
-
Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study. JMIR Mhealth Uhealth. 2018 Oct 09; 6(10):e11192.
Score: 0.049
-
Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study. Transplantation. 2018 09; 102(9):1514-1519.
Score: 0.049
-
Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study. Transplantation. 2018 07; 102(7):1148-1155.
Score: 0.048
-
Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants. Transplantation. 2018 03; 102(3):471-477.
Score: 0.047
-
MELD as a metric for survival benefit of liver transplantation. Am J Transplant. 2018 05; 18(5):1231-1237.
Score: 0.047
-
Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys. Am J Transplant. 2018 03; 18(3):617-624.
Score: 0.047